Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs WSM✓SelectedUSD · WSMGSK vs WSM performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs WSM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.3%
WSM return
+260.3%
Excess return
-195.0%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioWSMExcessAlpha
1D+0.5%+1.5%-0.9%+0.4%
7D+1.1%0.0%+1.1%+1.1%
30D+6.3%+5.1%+1.3%+6.1%
3M+1.8%+5.1%-3.3%+1.5%
6M+1.7%+48.6%-46.9%-0.1%
YTD+6.5%+44.2%-37.6%+4.9%
1Y+9.5%+38.1%-28.6%+7.8%
3Y+65.3%+257.2%-191.9%+54.7%
All+65.3%+260.3%-195.0%+54.7%

Cumulative growth

Daily Returns

Daily percentage return beside WSM.

Daily Out/Under-Performance

Portfolio return minus WSM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × WSM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded WSM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling